Evidence map›Paper›PMID 36529701›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Architecture Design and Catalytic Activity: Non-Noble Bimetallic CoFe/fe

Wenkang Miao, Ronghui Hao, Jingzhou Wang, Zihan Wang, Wenxin Lin, Heguang Liu, Zhenjie Feng, Yingchun Lyu, Qianqian Li, Dongling Jia and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Architecture Design and Catalytic Activity: Non-Noble Bimetallic CoFe/feAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Wenkang MiaoMaterials Genome Institute, Shanghai University, Shanghai, 200444, China.
Ronghui HaoMaterials Genome Institute, Shanghai University, Shanghai, 200444, China.
Jingzhou WangMaterials Genome Institute, Shanghai University, Shanghai, 200444, China.
Zihan WangMaterials Genome Institute, Shanghai University, Shanghai, 200444, China.
Wenxin LinSchool of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Heguang LiuSchool of Materials Science and Engineering, Xi'an University of Technology, Xi'an, 710048, China.
Zhenjie FengMaterials Genome Institute, Shanghai University, Shanghai, 200444, China.
Yingchun LyuMaterials Genome Institute, Shanghai University, Shanghai, 200444, China.
Qianqian LiMaterials Genome Institute, Shanghai University, Shanghai, 200444, China.ORCID https://orcid.org/0000-0001-7716-0481
Dongling JiaCollaborative Research Center, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
Runhai OuyangMaterials Genome Institute, Shanghai University, Shanghai, 200444, China.
Jipeng ChengSchool of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
Anmin NieCenter for High Pressure Science, State Key Laboratory of Metastable Materials Science and Technology, Yanshan University, Qinhuangdao, 066004, China.
Jinsong WuNanostructure Research Center, Wuhan University of Technology, Wuhan, 430070, China.

Funding

National Key Research and Development Program of China 2020YFB0704503National Natural Science Foundation of China 11972219
6 · The paper itself

Abstract

Non-noble metal catalysts now play a key role in promoting efficiently and economically catalytic reduction of CO

Indexed as

bimetallic CoFeCO2 hydrogenationnon-noble metal catalyststructure-property relationship

Identifiers

PMID36529701
PMCPMC9929264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.